This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Unit for Hours:H

Unit for Minutes: M

Loading text: $loading

Filter redirection page URL: /en-ie/events/

Login overlay needed?:

Filter Tags:All Medical indications|All Products|All Therapy Area

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successful

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successful

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:Not provided

Presentation Slide
Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Ireland/MP4/Webinar/zejula-program-gyncancer-xchange-2023.mp4

Presentation Slide 1
Presentation Slide 2
Presentation Slide 3
Presentation Slide 4
Presentation Slide 5

Webinar | English | 1:08:42

GyncancerXchange Centering on efficacy and QOL in advanced ovarian cancer: Experts discuss a patient case study in the 1L maintenance setting

While treatment outcomes for patients with gynaecological cancers have improved, clinical challenges and unmet needs remain. This video from global experts in the field of gynaecological cancers is a patient-centric event which aims to address key topics in first-line maintenance therapy for advanced ovarian cancer. This programme will feature discussions and insights to support treatment decision making centering on efficacy and quality of life in advanced ovarian cancer.

POM. Further information available from GlaxoSmithKline, 12 Riverwalk, Citywest, Business Campus, Dublin 24. Tel: 01-4955000

Zejula prescribing information and adverse event reporting information

Zejula 100 mg film-coated tablets prescribing information and adverse event reporting information

For additional Video/Journal Article Resources available Click Here

Speaker

Dr Antonio González-Martín

Dr Antonio González-Martín

MD, PhD

Director of Medical Oncology, Department and Director of Cancer Center, Clínica Universidad de Navarra, Madrid, Spain.

Prof Iain McNeish

Prof Iain McNeish

MD, PhD, FRCP

Chair in Oncology, Head of Division of Cancer, Imperial College London, London, United Kingdom.

Prof Michael Friedlander

Prof Michael Friedlander

AM, FRACP, PhD

Medical Oncologist, Royal Hospital for Women, Nelune Comprehensive Cancer Centre, Sydney, Australia.